Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

CDK 4-6 Inhibitors in Breast Cancer

ESMO Webinars 1000x250 Recorded Live

CDK 4-6 Inhibitors in Breast Cancer

The programme is designed to offer an overview of research activities in this area and review the current status and future prospects of CDK4-6 inhibitors in breast cancer.   

CDK 4-6 Inhibitors in Breast Cancer
Chair: Giuseppe Curigliano
Speakers: Stephen Johnston, Monica Arnedos, Hope Rugo

Watch now*

*The ESMO Webinar Series is freely available to all healthcare professionals working in Oncology.

Programme

  • Welcome and Introduction, Giuseppe Curigliano, MD, PhD, University of Milano, Istituto Europeo di Oncologia, Milan, Italy
  • Maximising Outcomes in Patients with HR+/HER2- Metastatic Breast Cancer: Expert Insights Into the Latest Data, Stephen Johnston, MA, PhD, FRCP, The Royal Marsden NHS Foundation Trust & The Institute of Cancer Research, London, UK
  • CDK 4-6 Inhibitors in Clinical Practice: Expert Perspectives and Recommendations, Monica Arnedos, MD, Institut Gustave Roussy, Villejuif, France
  • CDK 4-6 Inhibitors in Early Breast Cancer: Ongoing Trials and Definition of High Risk Population, Hope Rugo, MD, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, US
  • Q & A and Closing Remarks, Giuseppe Curigliano, MD, PhD, University of Milano, Istituto Europeo di Oncologia, Milan, Italy

Learning objectives

  • To provide an update on the clinical role of CDK 4-6 inhibitors in the management of breast cancer
  • To contextualise the latest data with CDK 4-6 inhibitors and implications on treatment outcomes in patients with HR+/HER2- metastatic breast cancer
  • To provide an update on research efforts with CDK 4-6 inhibitors in early breast cancer 

Watch now*

*The ESMO Webinar Series is freely available to all healthcare professionals working in Oncology.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings